Gilead's coronavirus treatment remdesivir to cost $3,120 per U.S. patient with private insurance

  • 📰 CNBC
  • ⏱ Reading Time:
  • 37 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 72%

United States Headlines News

United States Latest News,United States Headlines

“We decided to price this, in this very extraordinary time, in a unique way.” Gilead CEO Daniel O’Day discusses pricing for the company’s coronavirus treatment drug remdesivir.

it will sell remdesivir for $390 per vial to governments "of developed countries" around the world, and the price for U.S. private insurance companies will stand at $520 per vial. In the U.S., that means Gilead will charge a lower price for government programs like Medicare and a higher price for privately insured people.

While there are still no Covid-19 treatments approved by the Food and Drug Administration, scientists have found some success in shortening the recovery time of severely ill patients by using remdesivir. Given the potential to reduce costs for hospitals and to save lives, Gilead said its price of $390 per vial is "well below" the drug's value.

It has taken nearly two months for the company to announce a price for remdesivir since it received emergency authorization from the FDA to treat Covid-19 patients. In his open letter, O'Day said the pricing decision carried "significant responsibility" as it is the first antiviral drug shown to effectively treat Covid-19 in a major clinical trial.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

?... May 28, 2016 Gilead: A Trump Stock Worth Considering...

Vitamin C and zinc. Also, hydroxychloroquine has been known for 15 years to dismantle Corona viruses. Absolutely a corrupt system

That isn't called price gouging. That's price trenching. The gov't ought to use the law for emergency procurement and pay them 10% above cost. Nobody should be able to profit off the misfortune of the world. That goes for PPE suppliers too

Research funded by American taxpayers. Profits to a company. Medicate for All now.

$390 is a crazy ripoff, over $520!? What the actual hell?

What a load of crap! Americans get screwed again

Completely wild that a company called Gilead would be terrible at optics.

Yes charge Americans more so that we can charge the ROW less. Makes sense.

Wasn't Obamacare supposed to solve these problems?

An ethical, moral company during this pandemic. No one should have any complaints about their pricing.

so big pharma wins again. coincidence dumpobamacare

And people still wonder why young Americans prefer democratic socialism.

Really now!

Hmmm, while hydroxychloroquine that Trump talked about is less than 1$ per pill.

You notice..he didn't answer the question if they are getting any profit.

He say ten years in development but not the 12 years it has been in use. Also a significant amount of taxpayer money was provided for the initial development and tax $'s thru universities have done most of the research on alternative uses. Cost to make rumored at less than $20

Here its goes👇 Once you see Global Market carnage, immediately two flash news start pouring👉MEDIA ✍️Coronavirus vaccines success story, near dates for launch ✍️Second wave reason for downfall Investor getting wise & don't get trapped on such News played by Media Houses🤠

Pharmaceutical companies really want to be like Marie Antoinette, huh... 🤣

Profiting off a pandemic. You've shown us who you are now!

people will rather quarantine than spend $3,100 for a pill that probably wont work, and will probably have a million side effects. coronavirus

After extensive lobbying, we decided this is the max we can extort.

yes, the way that makes him the most money.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Gilead prices COVID-19 drug candidate remdesivir at $2,340 per patient in U.S.Gilead Sciences Inc has priced its COVID-19 drug candidate remdesivir at $390 per vial for the United States and governments of other developed countries, it said on Monday, setting the price of a five-day course at $2,340 per patient. See? It's all about MONEY gotta make a buck while people die
Source: Reuters - 🏆 2. / 97 Read more »

Coronavirus updates: More states close bars, slow reopening plans; Gilead Sciences sets price for remdesivir treatmentsMore states were slowing reopening plans Monday amid a national boom in coronavirus cases, although one Arizona mayor is unmoved by the ominous trend in his state. Ok I do not want to sleep alone What can you say about people who never learn? You have to learn from others mistakes because you'll never live long enough to make them all yourself.
Source: USATODAY - 🏆 100. / 63 Read more »

Coronavirus live updates: Gilead announces remdesivir pricing; U.K. eyes big investments to rebuild economyThe coronavirus has infected more than 10.15 million people around the world as of Monday, killing at least 502,048 people. Between unmarked black delivery vans and the company name Gilead, I may have to give up watching HandmaidsOnHulu or else start looking to relocate to Canada. weebiejeebies HandmaidsTale Gilead pharmaceutical
Source: CNBC - 🏆 12. / 72 Read more »

Elon Musk’s New Nemesis: Rivian Founder R.J. Scaringe Has A $3 Billion War Chest And Tesla In His HeadlightsCheck the rearview mirror, Tesla. Electric vehicle automaker Rivian has major investments from Amazon, Ford and the Saudis—and is ready to roll. ❤️ The movie about Tesla takes a turn for more drama about wit and conceptual innovation. Cheers Article doesn’t touch on the elephant in the room - this is an EV that folks in the O&G industry are salivating over.
Source: Forbes - 🏆 394. / 53 Read more »

Gilead prices COVID-19 drug candidate remdesivir at $2,340 per patient in U.S.Gilead Sciences Inc has priced its COVID-19 drug candidate remdesivir at $390 per vial for the United States and governments of other developed countries, it said on Monday, setting the price of a five-day course at $2,340 per patient. See? It's all about MONEY gotta make a buck while people die
Source: Reuters - 🏆 2. / 97 Read more »

Coronavirus live updates: Gilead announces remdesivir pricing; U.K. eyes big investments to rebuild economyThe coronavirus has infected more than 10.15 million people around the world as of Monday, killing at least 502,048 people. Between unmarked black delivery vans and the company name Gilead, I may have to give up watching HandmaidsOnHulu or else start looking to relocate to Canada. weebiejeebies HandmaidsTale Gilead pharmaceutical
Source: CNBC - 🏆 12. / 72 Read more »